NCT02731157View on ClinicalTrials.gov

Rejuvesol® Washed RBC in Sickle Cell Patients Requiring Frequent Transfusions

PHASE4CompletedINTERVENTIONAL
Enrollment

4

Participants

Timeline

Start Date

December 31, 2016

Primary Completion Date

December 31, 2017

Study Completion Date

December 31, 2017

Conditions
Sickle Cell Disease
Interventions
DRUG

Rejuvesol

PROCEDURE

Blood transfusion

Only transfusions necessary for the treatment of the sickle cell disease will be given for the purpose of the study.

Trial Locations (2)

27710

Duke Univeristy Medical Center, Durham

Unknown

University of North Carolina at Chapel Hill, Chapel Hill

Sponsors

Lead Sponsor

Duke University
All Listed Sponsors
lead

Duke University

OTHER